INmune Bio Inc
NASDAQ:INMB

Watchlist Manager
INmune Bio Inc Logo
INmune Bio Inc
NASDAQ:INMB
Watchlist
Price: 1.56 USD -2.5% Market Closed
Market Cap: 41.5m USD

Intrinsic Value

The intrinsic value of one INMB stock under the Base Case scenario is 4.78 USD. Compared to the current market price of 1.56 USD, INmune Bio Inc is Undervalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

INMB Intrinsic Value
4.78 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
INmune Bio Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about INMB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is INMB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for INmune Bio Inc.

Explain Valuation
Compare INMB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about INMB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
INmune Bio Inc

Current Assets 30.7m
Cash & Short-Term Investments 27.7m
Receivables 2.5m
Other Current Assets 472k
Non-Current Assets 2.7m
PP&E 1.9m
Other Non-Current Assets 746k
Current Liabilities 7.4m
Accounts Payable 6.9m
Accrued Liabilities 457k
Non-Current Liabilities 623k
Other Non-Current Liabilities 623k
Efficiency

Free Cash Flow Analysis
INmune Bio Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
INmune Bio Inc

Revenue
50k USD
Operating Expenses
-51.4m USD
Operating Income
-51.4m USD
Other Expenses
1.5m USD
Net Income
-49.9m USD
Fundamental Scores

INMB Profitability Score
Profitability Due Diligence

INmune Bio Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

11/100
Profitability
Score

INmune Bio Inc's profitability score is 11/100. The higher the profitability score, the more profitable the company is.

INMB Solvency Score
Solvency Due Diligence

INmune Bio Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
49/100
Solvency
Score

INmune Bio Inc's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INMB Price Targets Summary
INmune Bio Inc

Wall Street analysts forecast INMB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INMB is 5.36 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.

Lowest
Price Target
2.02 USD
29% Upside
Average
Price Target
5.36 USD
243% Upside
Highest
Price Target
8.4 USD
438% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

INmune Bio Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for INMB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

INMB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one INMB stock?

The intrinsic value of one INMB stock under the Base Case scenario is 4.78 USD.

Is INMB stock undervalued or overvalued?

Compared to the current market price of 1.56 USD, INmune Bio Inc is Undervalued by 67%.

Back to Top